A case of advanced hepatocellular carcinoma who died of metabolic encephalopathy early in the course of treatment with sorafenib with marked changes in imaging findings-Reference-Cited by-同舟云学术

A case of advanced hepatocellular carcinoma who died of metabolic encephalopathy early in the course of treatment with sorafenib with marked changes in imaging findings

Published:2010 Issue:5 Volume:51 Page:227-235
ISSN:0451-4203
Container-title:Kanzo
language:ja
Short-container-title:Kanzo

Author:

Sugimoto Katsutoshi,Saito Kazuhiro,Honjo Mitsuyoshi,Miyata Yuki,Sano Takatomo,Ichimura Shigeki,Murashima Eigaku,Taira Junichi,Yamada Kota,Furuichi Yoshihiro,Yamada Masahiko,Imai Yasuharu,Nakamura Ikuo,Moriyasu Fuminori

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

http://www.jstage.jst.go.jp/article/kanzo/51/5/51_5_227/_pdf

Reference16 articles.

1. Sorafenib in Advanced Hepatocellular Carcinoma

2. A case of advanced hepatocellular carcinoma died of metabolic encephalopathy on the early course of treatment with sorafenib

3. Gastrointestinal Stromal Tumors Treated with Imatinib: Monitoring Response with Contrast-Enhanced Sonography

4. 4) Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2009; 92: 205-216

5. Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin/gimeracil/oteracil/tegafur/sorafenib;Reactions Weekly;2024-08-31

2. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US;Liver International;2013-01-11

3. A case of hepatocellular carcinoma treated sorafenib therapy showing interesting clinical course about treatment interruption;Kanzo;2012

4. Hepatocellular carcinoma showing tumor stain disappearance with sorafenib treatment and reappearance after treatment reduction and interruption;Kanzo;2011